
BioDelivery Sciences International BDSI
Annual report 2021
added 12-23-2023
BioDelivery Sciences International Total Inventories 2011-2026 | BDSI
Annual Total Inventories BioDelivery Sciences International
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 23.7 M | 17.4 M | 11.3 M | 5.41 M | 6.09 M | 3.37 M | 2.56 M | 1.83 M | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 23.7 M | 1.83 M | 8.96 M |
Quarterly Total Inventories BioDelivery Sciences International
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 23.7 M | 23.1 M | 18.7 M | 17 M | 17.4 M | 18.9 M | 17.8 M | 15 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 5.41 M | 5.41 M | 5.41 M | 5.41 M | 6.09 M | 6.09 M | 6.09 M | 6.09 M | 3.37 M | 3.37 M | 3.37 M | 3.37 M | 2.56 M | 2.56 M | 2.56 M | 2.56 M | 1.83 M | 1.83 M | 1.83 M | 1.83 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.7 M | 1.83 M | 8.56 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aptorum Group Limited
APM
|
39.1 K | $ 0.89 | 1.48 % | $ 6.54 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
91.7 M | $ 22.2 | -2.07 % | $ 3.68 B | ||
|
ImmuCell Corporation
ICCC
|
9.27 M | $ 8.44 | 1.08 % | $ 76.2 M | ||
|
Innoviva
INVA
|
39.2 M | $ 23.05 | -2.7 % | $ 1.55 B | ||
|
Jaguar Health
JAGX
|
8.6 M | $ 0.23 | -6.64 % | $ 536 K | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.05 | -0.98 % | $ 433 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 22.37 | -3.95 % | $ 2.85 B | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.41 | -4.73 % | $ 375 M | ||
|
Madrigal Pharmaceuticals
MDGL
|
74.8 M | $ 518.58 | 0.37 % | $ 11.6 B | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |